Novartis Aktie
114,80
EUR
-1,30
EUR
-1,12
%
107,96
CHF
+0,48
CHF
+0,45
%
Werbung
Novartis Aktie Analyse
| 17.04.13 | Novartis kaufen | UBS AG | |
| 15.04.13 | Novartis halten | Barclays Capital | |
| 27.03.13 | Novartis kaufen | UBS AG | |
| 01.03.13 | Novartis kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.02.13 | Novartis kaufen | Société Générale Group S.A. (SG) | |
| 06.02.13 | Novartis kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.13 | Novartis kaufen | UBS AG | |
| 29.01.13 | Novartis kaufen | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 28.01.13 | Novartis halten | Goldman Sachs Group Inc. | |
| 24.01.13 | Novartis Kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.01.13 | Novartis Halten | Credit Suisse Group | |
| 24.01.13 | Novartis | Citigroup Corp. | |
| 24.01.13 | Novartis | Exane-BNP Paribas SA | |
| 22.01.13 | Novartis | Exane-BNP Paribas SA | |
| 16.01.13 | Novartis halten | Hamburger Sparkasse AG (Haspa) | |
| 14.01.13 | Novartis verkaufen | Vontobel Research | |
| 11.01.13 | Novartis verkaufen | Vontobel Research | |
| 10.01.13 | Novartis halten | Independent Research GmbH | |
| 13.12.12 | Novartis hold | Deutsche Bank AG | |
| 12.12.12 | Novartis outperform | Credit Suisse Group | |
| 11.12.12 | Novartis halten | Norddeutsche Landesbank (Nord/LB) | |
| 11.12.12 | Novartis reduce | Vontobel Research | |
| 10.12.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 30.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 27.11.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 21.11.12 | Novartis reduce | Vontobel Research | |
| 20.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 20.11.12 | Novartis buy | Sarasin Research | |
| 16.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 15.11.12 | Novartis buy | UBS AG | |
| 15.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 12.11.12 | Novartis outperform | Credit Suisse Group | |
| 08.11.12 | Novartis reduce | Vontobel Research | |
| 08.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 07.11.12 | Novartis reduce | Vontobel Research | |
| 06.11.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 05.11.12 | Novartis neutral | Citigroup Corp. | |
| 02.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 30.10.12 | Novartis buy | Deutsche Bank AG | |
| 29.10.12 | Novartis halten | Independent Research GmbH | |
| 29.10.12 | Novartis outperform | Credit Suisse Group | |
| 26.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 26.10.12 | Novartis reduce | Vontobel Research | |
| 25.10.12 | Novartis buy | Sarasin Research | |
| 25.10.12 | Novartis reduce | Vontobel Research | |
| 24.10.12 | Novartis underperform | Cheuvreux SA | |
| 24.10.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 23.10.12 | Novartis buy | Nomura | |
| 19.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
Werbung
Werbung